Anders Skyrud Danielsen
- PhD research fellow
Doctoral Research Fellow in the group and a PhD student at the University of Oslo, working on the ResCan project in collaboration with the Norwegian Institute of Public Health. His research focuses on the epidemiology of resistant microbes.
Short background:
- MPhil in International Community Health at the University of Oslo, 2018
- Specialisation in epidemiology
- Research Assistant at the Cancer Registry of Norway, 2018-2020
- Adviser at the Norwegian Institute of Public Health, 2020-2021
- Doctoral Research Fellow at the Oslo University Hospital, 2021-
Publications 2024
'Bloodstream infection': A valuable concept we should keep in our toolbox
J Infect, 89 (4), 106236
DOI 10.1016/j.jinf.2024.106236, PubMed 39097005
Patient perspectives on infection prevention and control in cancer care: a survey of knowledge and attitudes among persons with cancer and their next of kin
J Hosp Infect, 146, 21-30
DOI 10.1016/j.jhin.2024.01.012, PubMed 38311296
Estimating vaccine effectiveness against COVID-19 using cause-specific sick leave as an indicator: a nationwide population-based cohort study, Norway, July 2021 - December 2022
BMC Public Health, 24 (1), 1861
DOI 10.1186/s12889-024-19374-0, PubMed 38992631
Publications 2023
The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008-2018: expanding surveillance using existing laboratory and register data
Eur J Clin Microbiol Infect Dis, 43 (1), 121-132
DOI 10.1007/s10096-023-04698-3, PubMed 37980302
Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models
BMC Infect Dis, 23 (1), 247
DOI 10.1186/s12879-023-08182-3, PubMed 37072711
Clusters of healthcare-associated SARS-CoV-2 infections in Norwegian hospitals detected by a fully automatic register-based surveillance system
J Hosp Infect, 135, 50-54
DOI 10.1016/j.jhin.2023.02.014, PubMed 36913981
Publications 2022
Register-based surveillance of COVID-19 in nursing homes
Tidsskr Nor Laegeforen, 142 (8)
DOI 10.4045/tidsskr.21.0906, PubMed 35635409
Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial
Radiology, 303 (1), E23
DOI 10.1148/radiol.229003, PubMed 35312347
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018
Breast Care (Basel), 17 (5), 486-494
DOI 10.1159/000524564, PubMed 36684407
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021
BMC Med, 20 (1), 278
DOI 10.1186/s12916-022-02480-4, PubMed 36050718
High vaccine effectiveness against coronavirus disease 2019 (COVID-19) and severe disease among residents and staff of long-term care facilities in Norway, November 2020-June 2021
Antimicrob Steward Healthc Epidemiol, 2 (1), e10
DOI 10.1017/ash.2021.246, PubMed 36310780
Publications 2021
Does it matter for the radiologists' performance whether they read short or long batches in organized mammographic screening?
Eur Radiol, 31 (12), 9548-9555
DOI 10.1007/s00330-021-08010-9, PubMed 34110427
Birthing parents had a lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15th of February 2020 to 15th of May 2021
Infect Prev Pract, 3 (4), 100183
DOI 10.1016/j.infpip.2021.100183, PubMed 34786552
Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography Screening
Radiology, 300 (1), 66-76
DOI 10.1148/radiol.2021203936, PubMed 33973840
SARS-CoV-2 among employees in the health and care service
Tidsskr. Nor. Laegeforen., 141 (3), 237-242
SARS-CoV-2 in health and care staff in Norway, 2020
Tidsskr Nor Laegeforen, 141 (3)
DOI 10.4045/tidsskr.20.1048, PubMed 33624971
Self-reported Pain Associated With Screening With Digital Breast Tomosynthesis
J Breast Imaging, 3 (1), 25-33
DOI 10.1093/jbi/wbaa096, PubMed 38424841
Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
Euro Surveill, 26 (35)
DOI 10.2807/1560-7917.ES.2021.26.35.2100793, PubMed 34477054
Assessment of breast positioning criteria in mammographic screening: Agreement between artificial intelligence software and radiographers
J Med Screen, 28 (4), 448-455
DOI 10.1177/0969141321998718, PubMed 33715511
Mammographic features and screening outcome in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography
Eur J Radiol, 141, 109753
DOI 10.1016/j.ejrad.2021.109753, PubMed 34053786
Publications 2020
Time of day and mammographic reader performance in a population-based breast cancer screening programme
J Med Screen, 28 (3), 0969141320953206-301
DOI 10.1177/0969141320953206, PubMed 32862773
[Asylum seekers’ health and use of health services in Norway]
Tidsskr Nor Laegeforen, 140 (4)
DOI 10.4045/tidsskr.19.0470, PubMed 32192269
Asylum seekers' health and use of health services in Norway
Tidsskr. Nor. Laegeforen., 140 (4), 363-367
Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial
Radiology, 297 (3), 522-531
DOI 10.1148/radiol.2020201150, PubMed 32930649
Surgical treatment of breast cancer in Norway 2003-2018
Tidsskr Nor Laegeforen, 140 (15)
DOI 10.4045/tidsskr.20.0090, PubMed 33118768
Publications 2019
Targeting TB or MRSA in Norwegian municipalities during 'the refugee crisis' of 2015: a framework for priority setting in screening
Euro Surveill, 24 (38)
DOI 10.2807/1560-7917.ES.2019.24.38.1800676, PubMed 31552819